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Hormone-secreting cells within pancreatic islets of
Langerhans play important roles in metabolic ho-
meostasis and disease. However, their transcrip-
tional characterization is still incomplete. Here, we
sequenced the transcriptomes of thousands of hu-
man islet cells from healthy and type 2 diabetic do-
nors. We could define specific genetic programs for
each individual endocrine and exocrine cell type,
even for rare d, g, ε, and stellate cells, and revealed
subpopulations of a, b, and acinar cells. Intriguingly,
d cells expressed several important receptors, indi-
cating an unrecognized importance of these cells in
integrating paracrine and systemic metabolic sig-
nals. Genes previously associated with obesity or
diabetes were found to correlate with BMI. Finally,
comparing healthy and T2D transcriptomes in a
cell-type resolved manner uncovered candidates
for future functional studies. Altogether, our analyses
demonstrate the utility of the generated single-cell
gene expression resource.
INTRODUCTION
The pancreas is a vital organ for maintaining metabolic homeo-
stasis, consisting largely of exocrine ductal and acinar cells that
produce and deliver digestive enzymes into the gut. Intermingled
in the exocrine regions are the islets of Langerhans, comprised of
at least five distinct endocrine cell types: a cells (secreting
glucagon,GCG), b cells (insulin, INS),g/PPcells (pancreatic poly-
peptide, PPY), d cells (somatostatin, SST), and ε cells (ghrelin,Cell Metabolism 24, 593–607, Oc
This is an open access article under the CC BY-NGHRL), together making up less than 2% of pancreas mass.
The cell-type composition within human islets of Langerhans is
50%–60% b cells, 30%–45% a cells, less than 10% g and d cells,
and less than 1% ε cells (Cabrera et al., 2006); however, this
composition varies among individuals. The endocrine islets are
essential for blood glucose homeostasis and key players in the
development of diabetes, which is characterized by loss of
functional b cells (Kahn et al., 2006). Type 2 diabetes (T2D) is
caused by a combination of increasing INS resistance in periph-
eral tissues and reduced mass or dysfunction of the b cells.
In order to understand the molecular mechanism governing the
function of the pancreas, it has been important to investigate
cell-type-specific gene expression in health and disease. Due to
the cellular heterogeneity within the islets of Langerhans, it is
challenging to interpret whole-islet transcriptome data, and fluo-
rescence-activated cell sorting (FACS)-enriched transcriptome
data only exist for a few cell types. In particular, it is hard to distin-
guish cell-type compositional differences from alterations occur-
ringwithin specificcell typesandaddresswhether subpopulations
exist. These issues could be resolved using single-cell transcrip-
tomics (Sandberg, 2014; Stegle et al., 2015). The two studies to
date have had too few cells (Li et al., 2016; Wang et al., 2016) to
control for inter-individual differences and profile rare cells.
Here, we used single-cell RNA-sequencing (RNA-seq) to
generate transcriptional profiles of endocrine and exocrine cell
types of the human pancreas in healthy and T2D individuals.
We could reveal subpopulations in endocrine and exocrine cell
types, identify genes with interesting correlations to BMI in spe-
cific cell types, and find alterations in gene expression in T2D.RESULTS
Pancreatic tissue and cultured islets were obtained from six
healthy and four T2D donors of varying BMI and age (Figure 1A).tober 11, 2016 ª 2016 The Authors. Published by Elsevier Inc. 593
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Functionality of the islets was confirmedwith glucose-stimulated
INS secretion (GSIS) (Figure S1A, available online). Islets were
dissociated into single-cell suspension and viable individual cells
were distributed via FACS into 384-well plates containing lysis
buffer (Figure S1B). Next, single-cell cDNA libraries were gener-
ated using the Smart-seq2 protocol (Picelli et al., 2014), which
enables the capture of full-length poly(A)+ RNAs with higher
sensitivity and more even transcriptome coverage than with pre-
vious protocols (Picelli et al., 2013; Ramsko¨ld et al., 2012; Stegle
et al., 2015). Each single-cell transcriptome was sequenced to
750,000 reads, sufficient for cell-type classification (Pollen
et al., 2014). Gene expression was quantified as reads per kilo-
base of transcript per million mapped reads (RPKM) using
rpkmforgenes (Ramsko¨ld et al., 2009).
Since certain endocrine populations (e.g., ε cells) are present
within the islets at low frequencies, we sequenced 350 cells
from each donor. In total we obtained 3,386 cells, and after strin-
gent quality control filtering (see Supplemental Experimental
Procedures; Figures S1C–S1H), we retained 2,209 cells. As con-
trols, we also sequenced 16 empty wells for six of the donors (in
total 96 wells). The sequencing reads detected in the controls,
originating from low levels (<0.5%) of RNA contamination from
FACS or library preparation, were below the quality thresholds.
Cell-Type Identification and Expression
We explored the single-cell transcriptome data in an unbiased
manner by identifying biological variation in gene expression
(Brennecke et al., 2013) (Table S1) and projecting all cells onto
two dimensions using t-distributed stochastic neighbor embed-
ding (t-SNE) (Van der Maaten and Hinton, 2008). The major sep-
aration of cells reflected gene expression differences between
exocrine and endocrine cell types (Figure 1B), with two clusters
corresponding to exocrine acinar (n = 185) and ductal (n = 386)
cells based on expression of their respective markers, PRSS1
and KRT19 (Figure 1C), whereas the third cluster contained the
endocrine cells (n = 1,554). The five smaller observed clusters
(Figure 1B) corresponded to pancreatic stellate cells (PSCs;
n = 54, high expression of collagen genes, matrix metalloprotei-
nases, TIMP1, FN1, POSTN, and ACTA2) (Liu and Du, 2015),
endothelial cells (n = 16, expressing PLVAP, CD31/PECAM1,
VWF, and ANGPT2), mast cells (n = 7, expressing tryptase genes
TPSB2, TPSD1, and TPSAB1), antigen-presenting MHC class II
cells (n = 5, high expression of CD74, CD86, HLA-DPA1, HLA-
DPB1, and HLA-DRA) and two cells of unknown origin (‘‘unclas-
sified exocrine,’’ high expression of, e.g., RCAN1, SPP1, andFigure 1. Single-Cell Transcriptome Analyses of Human Pancreas
(A) Table of donor information (HbA1c, glycated hemoglobin).
(B) Projection of all cells (n = 2,209) onto two dimensions using t-SNE based on
variation across cells.
(C) Expression (log2RPKM) of exocrine marker genes (PRSS1 for acinar and KRT
(D) Boxplots displaying the expression levels in the seven obtained clusters o
(TPSAB1), pancreatic stellate cells (COL1A2), and endothelial cells (PLVAP). Med
indicate the 25th and 75th percentiles. Bars extend to extreme data points and o
(E) Two-dimensional t-SNE projection of the endocrine cells (n = 1,554) based o
variation across endocrine cells. The obtained clusters were assigned to the
correspond to cell types and shadings indicate donors. Healthy and T2D cells ar
(F) t-SNE representation of cells as in (E) illustrating the expression of the five end
log2RPKM values, with white and red colors corresponding to minimum (zero) an
(G) Bar graphs showing the percentage of cells classified into cell types, per donNOV ) (Figure 1D; Table S1). The cell clusters were obtained
without using knowledge of cell types or prior purification of
cell populations.
To resolve the various endocrine cell types, we performed a
similar analysis only on the endocrine cells, which separated
them into discrete clusters (Figure 1E) with distinct hormone
expression and allowed their classification into a, b, g, d, and ε
cells (Figure 1F). The endocrine cells clustered together irrespec-
tively of inter-individual differences and T2D status (Figure 1E),
demonstrating that cell-type-specific expressions are associ-
atedwith the dominating transcriptome patterns. A group of cells
characterized by a high expression of multiple hormones and an
elevated number of expressed genes was detected among b
cells (‘‘co-expression,’’ n = 39; Figures 1E and S2A). Although
such cells have been reported (Blodgett et al., 2015), this group
likely corresponds to cell doublets and therefore was excluded.
Indeed, image analyses identified 0.3% cell doublets during sin-
gle-cell sorting (Supplemental Experimental Procedures), and
hormone co-expression was found in 0.9%–1.8% of the re-
maining endocrine cells after removal of the potential cell
doublets (Figures S2C and S2D). A second cluster of cells
(unclassified endocrine, n = 41; Figure 1E, white group) charac-
terized by low number of genes expressed (Figure S2B) was also
excluded from the analyses.
Variations in Cell-Type Composition
The composition of cells profiled from each donor varied sub-
stantially (Figures 1G and S3A; Table S1), both in terms of
exocrine and endocrine cells and within the endocrine cell types.
To determine if the observed composition of cell types corre-
sponded to cell types present in the non-dissociated tissue
and islet preparations, we performed immunohistochemistry
staining with GCG and INS on the pancreatic tissues and purified
islets (Figure S3B) (eight donors), and FACS analyses on disso-
ciated islets using antibodies targeting GCG, INS, and SST
(two donors) (Figure S3C). Analyses of the estimated fractions
of a, b, and d cells in the tissue and islets revealed that a cells
were more abundant and b cells less numerous in the single-
cell data than in the corresponding tissue and islet preparations
(Figure S3D). This could reflect lower survival of b cells during
single-cell dissociation and FACS. For g and d cells, the numbers
were in general agreement except for an increase of g cells in the
single-cell data in one T2D donor (Figure 1G). We concluded that
single-cell dissociation and FACS introduce a systematic bias
in cell-type proportions. In order to compare single-cell tothe expression values (log2RPKM) of the 1,000 genes with highest biological
19 for ductal cells) overlaid onto the 2D t-SNE as shown in (B).
f marker genes for MHC class II antigen-presenting cells (CD86), mast cells
ian and mean are shown as a line and circle, respectively. Edges of each box
utliers are plotted as gray dots.
n the expression values (log2RPKM) of the 500 genes with highest biological
endocrine cell types based on the hormone expression levels in (F). Colors
e marked with circles and triangles, respectively.
ocrine hormones: GCG, INS, PPY, SST, and GHRL. Color scale is according to
d maximum (log2RPKM = 21) expression, respectively.
or.
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whole-islet RNA-seq, we correlated the average gene ex-
pression in single cells with the expression in whole-islet
sequencing from the same donors. This analysis demonstrated
that single-cell data give a reliable view of the whole islet
(Spearman’s r, 0.86–0.92; Figure S4A) and that with only tens
of single cells, correlations start to saturate (Figure S4B).
Gene Expression Signatures of Endocrine Cells
Theaveragenumberofgenesexpressedpercell typewas roughly
5,500 for endocrine and 7,000 for exocrine cells (Figure 2A), with
slight variation using higher expression threshold (Figure S1H).
Strikingly, hormone expression accounted for a large fraction of
the transcriptome in endocrine cells, reflecting their functional
dedication to hormone secretion, with INS, PPY, and SST tran-
scripts alone accounting for50%of the total cellular transcripts
in the b,g, and d cells, respectively (Figure 2B). In a and ε cells, the
expressionofGCGandGHRL, respectively, accounted for20%
of their transcriptomes (Figure 2B; Table S1).
Next, we investigated the specific gene expression in the six
major cell types (a, b, g, d, acinar, and ductal cells) to shed light
on their respective functions, using one-way ANOVA on the five
healthy male donors (to exclude confounding effects of sex and
disease). This analysis revealed several hundred genes that were
expressed at significantly higher levels in a, b, g, d, or exocrine
cell types (Table S2; Figures 2C, 2D, and 3C). Most of the previ-
ous transcriptome studies of the pancreas have investigated
whole islets or used FACS to sort for either a or b cells followed
by microarray analysis or RNA-seq. For a or b cells, several
studies in mouse (Benner et al., 2014; Ku et al., 2012) or human
islets (Blodgett et al., 2015; Bramswig et al., 2013; Dorrell et al.,
2011; Nica et al., 2013) have found cell-type-specific transcripts
with 2-fold or higher expression levels than in other cell types.
The genes we identified as being a and b cell enriched overlap-
ped largely with the previous studies. For example, in a cells we
detected known markers such as GCG, LOXL4, DPP4, GC, and
FAP (Figure 2E) (Dorrell et al., 2011). Importantly, RNA in situ hy-
bridization verified significant co-expression of FAP and GCG in
a cells (Figure 2F; Table S3). We also observed cell-type en-
riched expression of genes that have not previously been linked
to specific endocrine cell types.GPR119 has been identified as a
potential target for the treatment of diabetes, since agonists
have been shown to enhance nutrient-stimulated INS andFigure 2. Characterization of Endocrine Cell Transcriptomes
(A) Boxplots showing the number of genes detected in each cell type (expressi
respectively. Edges of each box indicate the 25th and 75th percentiles. Bars ext
(B) Percentage of all mRNAs in respect to the total transcriptome in each cell t
descending order (x axis).
(C) Table with the number of significantly enriched genes in a, b, g, d, acinar, and
(D) Heatmap with expression distributions for the top 25 enriched genes in each
based on the magnitude of expression range among the four endocrine cell types
endocrine and exocrine cell type, with labels indicating cell type and donor (top). C
heatmap contains the distribution of values across the cells for each cell type an
(E) Boxplots with the expression levels of selected cell-type enriched genes ident
LINC01099 for b cells; and LEPR and GHSR for d cells. Gene expression is sho
different donors. Median andmean are shown as a line and circle, respectively. Ed
data points and outliers are plotted as gray dots.
(F and G) Single-molecule RNA FISH on pancreatic tissue section. (F, left) A rep
(blue). (G, left) Islet (donor H5) co-stained with SST (green), LEPR (red), and DAPI (
and additional images in Table S3. Scale bar represents 25 mm.GLP-1 release and also to increase b cell mass in mice in vivo
(Chu et al., 2008; Gao et al., 2011). We could assign the expres-
sion of GPR119 primarily to a cells in humans (Figure 2E), in
contrast to previous reports (Chu et al., 2008; Odori et al., 2013).
In b cells, we found elevated expression levels of, e.g., INS,
IAPP, ADCYAP1, PDX1, MAFA, NKX6-1, and MEG3 (Figures
2D and 3B). Additionally, b cell-specific protein expression of
both PDX1 and NKX6-1 was verified using FACS analysis, where
the PDX1+/NKX6-1+ cell population coincided with the expres-
sion of b cell marker C-peptide protein (Figure S5A). We also
detected long non-coding RNAs, e.g., LINC01099, with expres-
sion restricted mainly to b cells (Figure 2E).
Transcriptional Profiling of Rare Endocrine Cell Types
The transcriptomes of g, d, and ε cells are largely unknown in hu-
man. We noted that many receptors were highest or exclusively
expressed in d cells (e.g., UNC5B, GABRB3, GABRG2, CASR,
FFAR4/GPR120, andKCNJ2) (Figure 2D; Table S2).We also iden-
tifiedpronouncedexpressionof the leptin receptor (LEPR) indcells
(Figure 2E). Previous studies in murine and human cells have re-
ported LEPR protein expression in a, b, and d cells (Kieffer et al.,
1996, 1997; Tudurı´ et al., 2009). RNA in situ hybridization validated
significant co-expression of LEPR and SST in d cells (Figure 2G;
Table S3). Expression of the GHRL receptor (GHSR) has been
reported on mouse a cells (Date et al., 2002), rat INS-1 b cell line
(Wierup et al., 2004), and to be partly localized to b cells in human
islets (Granata et al., 2007). Intriguingly, we uncovered that the
GHSRwas specifically expressed in d cells (Figure 2E).
We also identified genes specifically expressed in g cells, e.g.,
SERTM1, SPOCK1, ABCC9, and SLITRK6 (Figure 2D; Table S2),
none of which, to the best of our knowledge, have been assigned
to pancreatic or g cell functions. Among the 2,209 cellular tran-
scriptomes captured, seven were from ε cells. Analysis of these
cells allowed us to identify elevated expression of 39 genes,
including the expression of GHRL and GHRLOS. The ε cells
uniquely expressed several interesting receptors like NPY1R,
OPRK1, PTGER4, and ASGR1, and processing enzymes such
as PCSK6 (Figure 3A; Table S2).
Transcription Factor Expression in Endocrine Cells
We could confirm the expression of many transcription factors
in endocrine cells, e.g., ISL1 and NEUROD1, and restrictedon threshold, RPKM R 1). Median and mean are shown as a line and circle,
end to extreme data points and outliers are plotted as gray dots.
ype (Table S1), with genes ranked according to the expression magnitude in
ductal cells.
of the four endocrine cell types (a, b, g, and d cells). The genes were selected
. The expression profiles of the ten donors are shown separately and for each
olors correspond to standardized log2 expression values, where each cell in the
d donor.
ified in the differential expression analysis: FAP, DPP4, and GPR119 for a cells;
wn for a, b, g, d, ε, acinar, and ductal cells, with color shadings representing
ges of each box indicate the 25th and 75th percentiles. Bars extend to extreme
resentative islet (donor H5) co-stained with GCG (green), FAP (red), and DAPI
blue). (F and G, right) Zoom-in on merged or individual channels. Quantification
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expression of MAFA in b cells and IRX2 in a cells (Figure 3B).
However, many transcription factors were expressed in a subset
of endocrine or exocrine cells, including ARX expression in a and
g cells, in line with the increase in g and a cell numbers after
forced ARX expression in mouse embryonic islets (Collombat
et al., 2007). We found HHEX expression in both d and ductal
cells while MAFB expression was restricted to a, b, and d cells
(Figure 3B). We also detected several enrichments of factors in
particular cell types. For example,NKX6-3was enriched in d cells
and SIX2 and SIX3 were restricted to b cells. In g cells, we
observed significantly elevated expression of MEIS2, ETV1,
and ID4 (Figure 3B), whereas AFF3 was specifically expressed
in ε cells (Figure 3A).
Cell-Type-Specific Expression in Other Pancreatic Cell
Types
The transcriptomes of exocrine cell types had higher numbers of
significantly enriched genes, 332 and 408 genes, respectively,
for acinar and ductal cells (Figures 2C and 3C; Table S2). Addi-
tionally, we detected a large number of genes that were ex-
pressed at higher levels in both exocrine cell types but were
absent in endocrine cells (data not shown). The pancreatic stel-
late cells and endothelial cells also expressed a large number of
specific genes (Figure 3D; Table S2).
Using our cell-type-specific expression data, we assessed to
what extent cell-type-specific gene expression can be identified
from whole-islet sequencing (Taneera et al., 2012) by simply
correlating gene expression with cell-type-defining hormone or
marker gene expression. Our results indicate that only few of
the cell-type enriched genes would be captured, as our stron-
gest cell-type enriched genes were either seldom significant or
had low ranks (Figure S5B).
The Identification of Subpopulations and Cellular States
Inorder toexploreheterogeneitywithincell populations,we inves-
tigated the clustering of cells within each cell type. After assigning
cells to cell types, the secondstrongestdeterminant of thecellular
transcriptomes was inter-individual differences (Figure S6).
Clustering analysis after the removal of donor effect (see Sup-
plemental Experimental Procedures) uncovered subpopulations
of a, b, and acinar cells. For g, d, and ductal cells, no robust
separation was observed (Figure S6). Twelve a cells belonging
to multiple donors (both healthy and T2D) grouped separately
from all other a cells (Figures 4A and S6A). GCG expression
was similar in both clusters; however, differential expression
analysis showed a mild downregulation of several a enriched
genes (C10orf10, PEMT, PLCE1, ARRDC4, CRYBA2, LOXL4,Figure 3. Cell-Type-Specific Expression
(A) Heatmap showing ε cell enriched gene expression (rows) across the seven cell
shown on the top. Colors in the heatmap correspond to standardized log2 expres
across the cells for each cell type and donor.
(B) Heatmap with expression levels of transcription factors (rows) across the c
correspond to minimum (zero) and maximum (log2RPKM = 12) expression, respe
(C) Heatmapwith expression of significantly enriched genes (rows) in acinar and du
selected based on the magnitude of expression range between the two exocrine
(D) Heatmap showing the differentially expressed (DE) genes (columns) between
obtained using single-cell differential expression (SCDE), and only the genes with
shown. The colors in the heatmap correspond to standardized log2 expression va
the cells of each cell type.RGS4, and SMIM24) and a high expression of proliferation-asso-
ciated genes (e.g., TOP2A,MKI67,CENPF,BIRC5, andCDK1) in
these twelve cells (Figure 4A). Therefore, the rare a cells consti-
tuted proliferating a cells that were distinguished by a signature
of 439 significantly upregulated genes (Table S4). Importantly,
this group was not detectable before adjusting for donor effects
(Figure S6A). Searching for proliferative gene expression signa-
tures across the complete single-cell dataset revealed additional
acinar (n = 8) and ductal (n = 2) cells with expression of prolifer-
ative markers (Figure S7). The gene expression signatures of
these rare proliferating cells might provide clues to the mecha-
nisms of self-renewal of pancreatic tissue.
Sub-clustering of b cells revealed five clusters of cells with
combinatorial expression of RBP4, FFAR4/GPR120, ID1, ID2,
and ID3 (Figure 4B; Table S4). Cells of the five clusters expressed
INS at similar levels (Figure 4B). Interestingly, clusters 1 and 5 ex-
pressed RBP4 (also expressed in d cells; Figure 2D), an adipokine
primarily expressed in the liver and adipocytes (Klo¨ting et al.,
2007). Increased circulating levels ofRBP4are prominent in obese
andT2D individualsandcorrelatewith INS resistance in theperiph-
ery (Yanget al., 2005). The sameRBP4-expressingbcells (clusters
1 and 5) also express FFAR4.FFAR4agonists havebeen shown to
induce INS release inmouse pancreatic islets (Moran et al., 2014).
b cell clusters 1, 2, and 3 were characterized by expression of
ID1 and ID3, regulators of basic helix-loop-helix (bHLH) transcrip-
tion factors (Ling et al., 2014). To the best of our knowledge, these
subgroups of b cells have never been described before.
Finally, we identified two clusters of acinar cells (Figure 4C).
Cells belonging to cluster 1 were characterized by elevated
expression of inflammatory related genes (Figure 4C; Table S4),
including components of the MHC class II molecule, e.g.,
CD74,HLA-DMA,HLA-DRA, andHLA-DRB1 (Figure 4C). Cluster
1 also expressed pro-inflammatory chemokines (e.g., CXCL1,
CXCL6, CCL2, CCL20, and CX3CL1), cytokines (IL17C and
IL18), and transcription factors and immune regulators (STAT1,
NFKBIA,NFKBIZ,HIF1A, SOX4, andONECUT2). Cells of cluster
2 expressed higher levels of key acinar genes encoding secretory
digestive enzymes (e.g., CEL, CELA2A, and AMY) and important
transcription factors that regulate expression of digestive
enzymatic genes including PTF1A and RBPJL (Figure 4C).
Gene Expression Alterations with Increased Obesity
In order to investigate gene expression signatures relating to
obesity, we correlated the expression of each gene with donor
BMI for the five healthy males, separately per cell type (see Sup-
plemental Experimental Procedures; Table S5). Several of the
genes correlating with BMI have earlier been implicated intypes for the ten donors (columns). Labels indicating the cell type and donor are
sion values, where each cell in the heatmap contains the distribution of values
ells from the six cell types for the ten donors (columns). Blue and red colors
ctively.
ctal cells across the six cell types for the ten donors (columns). The geneswere
cell types. The heatmap was generated as in (A).
the pancreatic stellate (PSCs) and the endothelial cells (rows). The results were
a log2 fold change in expression of at least seven between the two groups are
lues, where each cell in the heatmap contains the distribution of values across
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Figure 4. Uncovering Subtypes of Endo-
crine and Exocrine Cells
(A) (Left) Two-dimensional t-SNE representation of
all a cells (n = 886, 10 donors) using donor-
normalized expression values of the 500 most
variable genes in a cells. Colored according to
cluster assignments. (Right) Heatmap illustrating
the top DE genes (columns) between the two a cell
clusters (rows). The colors in the heatmap corre-
spond to standardized log2 expression values,
where each cell in heatmap contains the distribu-
tion of values across the cells in each cluster.
(B) (Left) Two-dimensional t-SNE representation of
b cells (n = 270, 10 donors) using donor-normal-
ized expression values of the 50 most variable
genes in b cells. (Right) t-SNE representation of
cells, colored according to expression (log2RPKM)
of DE genes among the five clusters.
(C) (Left) Two-dimensional t-SNE projection of
acinar cells (n = 185, 10 donors) using donor-
normalized expression values of the 100 most
variable genes in acinar cells. (Right) Heatmaps
illustrating the top DE genes (columns) per
cell cluster (rows). The heatmap was generated
as in (A).obesity or diabetes progression. Expression of the PCSK1 inhib-
itor (PCSK1N) showed a strong positive correlationwith BMI in all
endocrine cell types (Figures 5A and 5B). PCSK1 converts pro-
hormones to active hormones with substrates such as INS,
SST, and enkephalins. Altered function of PCSK1 is associated
with obesity both in mouse and human (Nead et al., 2015). In
addition, transgenic mice overexpressing PCSK1N have an
obese phenotype (Wei et al., 2004). Analysis also revealed that
SCG5 was negatively correlated with BMI in all cell types (Fig-
ure 5B). SCG5 is a molecular chaperone of PCSK2, the enzyme
responsible for cleavage of pro-GCG to GCG and also involved
in pro-IAPP to IAPP processing (Braks and Martens, 1994;
Wang et al., 2001), implicating an a and b cell-related dysfunc-
tion in GCG and IAPP processing, respectively, correlating with
increasing BMI. Interestingly, PPDPF expression in a, b, d, and
ductal cells was positively correlated with BMI (Figure 5A).
PPDPF regulates exocrine pancreas development in zebrafish,
where overexpression leads to relative expansion of the exocrine600 Cell Metabolism 24, 593–607, October 11, 2016pancreas (Jiang et al., 2008). Finally, we
noted that CALM2 was negatively corre-
lated with BMI in endocrine (a, b, g, and
d) and ductal cells (Figures 5A and 5B),
which is of interest given the role of
calmodulins in calcium sensing and
signaling, e.g., in b cells and INS release
(Gilon et al., 2014). Naturally, previous
bulk analyses should, in principle, be
able to identify genes that are correlating
to BMI in all (or the most abundant) cell
types, whereas those specific to partic-
ular cell types would not be easily
revealed without single-cell resolution.
This is apparent when comparing correla-
tions obtained with all cells to correlationsbased on separate cell types (Figure 5C). For example, positive
correlations of INS, PPY, and SST in b, g, and d cells were stron-
ger in cell-type resolved analyses. Interestingly, several genes
with previous links to obesity and diabetes were correlating
with BMI in the cell-type resolved analyses, but were not corre-
lating in the bulk analyses (Figure 5C).
Gene Expression Alterations in T2D
Contrasting the transcriptomes from healthy and T2D individuals
in each cell type independently identified significant (adjusted
p value % 0.01) alterations in gene expression in endocrine
and exocrine cell types (Figure 6A; Table S6). INS deficiency in
T2D can result from decreased b cell mass and reduced INS pro-
duction in remaining b cells. Three out of four T2D donors had
lower numbers of b cells (Figure S3A), and we detected signifi-
cantly lower INS mRNA levels in T2D b cells (Figure 6B). The
most significant difference in b cells was a downregulation of
FXYD2 in T2D individuals (Figure 6B). FXYD2 encodes the
A B
C
(legend on next page)
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gamma subunit of an Na,K-ATPase. Mice lacking FXYD2 are
more glucose tolerant, have a substantial pancreatic b cell hy-
perplasia, and have increased plasma INS levels (Arystarkhova
et al., 2013). In line with these experiments, overexpression of
FXYD2 in renal cells reduced the rate of cell division (Wetzel
et al., 2004). Our data also revealed several important genes
that were upregulated in T2D b cells, e.g., GPD2 and LEPROTL1
(Figure 6B). GPD2 is one of two key enzymes of the NADH shut-
tles into mitochondria and aids the subsequent ATP production
and glucose-induced activation of mitochondrial metabolism
and INS secretion in b cells (Eto et al., 1999). Moreover,
LEPROTL1 is also known as endospanin-2. Overexpression of
the LEPROTL1 protein decreases the surface localization
of the leptin receptor (Se´ron et al., 2011) and the growth
hormone receptor (GHR) in cells (Touvier et al., 2009), thereby in-
hibiting the hormonal actions. Endospanin-1, a paralog of
LEPROTL1with similar activity (Se´ron et al., 2011), was recently
shown to be upregulated in obese mice, and silencing of the
gene restored central leptin responsiveness in these mice, lead-
ing to body weight loss (Vauthier et al., 2014).
We also observed transcriptional alterations in a cells of T2D
individuals. RGS4 has been shown to be a negative regulator
of GSIS in mouse MIN6 insulinoma cells via its inhibitory actions
on the M(3) muscarinic receptor (CHRM3) (Ruiz de Azua et al.,
2010). The expression of RGS4 and CHRM3 in pancreas has
not been established before and we detected them significantly
enriched in a and g cells, respectively (Table S2). We found a
significantly decreased expression of WFS1 in T2D a cells (Fig-
ure 6B; Table S6), in agreement with a recent study (Taneera
et al., 2012).
Finally, we used gene set enrichment analysis (GSEA) to inves-
tigate whether transcriptional alterations in T2D were enriched for
specific functional categories or previously defined gene signa-
tures. The analysis revealed that genes responsible for energy
metabolism in mitochondria and protein synthesis were signifi-
cantly downregulated in most cell types in T2D individuals (Fig-
ure6C;TableS7). In contrast, among thegenes foundupregulated
in T2D, we observed, for example, enrichment for apoptosis, dia-
betic nephropathy, and cytokine signaling (Figure 6C).
Functional Validation of GLP1R
GCG-like peptide receptor 1 (GLP1R), expressed in b and d cells
(Figure 7A), is of interest for targeted diabetic treatment due to
the ability of GLP1R agonists to induce GSIS in b cells (Nadkarni
et al., 2014). Moreover, GLP1 analogs (e.g., exenatide and lira-
glutide) are commonly used anti-diabetic drugs (Montanya,
2012). To validate the functionality of the isolated human islets,
we measured both the INS response to exenatide treatmentFigure 5. Gene Expression Correlates to Donor Physiological Charact
(A) Heatmap of gene expression associated with BMI in a cells (n = 417, healthy m
magnitude are ranked in descending order of coefficient. Cells (columns) are ord
(zero) and maximum (log2RPKM = 14) expression, respectively. The correspondin
(based on the cells from healthy male donors) are displayed on the right of the h
(B) Scatterplots showing the expression levels of four genes with a robust corre
between the expression and BMI, where m is the slope and b the y-intercept.
(C) Scatterplots of Spearman’s correlations of genes toward BMI computed base
(y axis). Colored are the genes with an absolute correlation coefficient of at least
correlation computed using all cells.
602 Cell Metabolism 24, 593–607, October 11, 2016and the GLP1R protein expression. Immunohistochemistry de-
tected GLP1R solely in the endocrine islets and predominantly
in b cell enriched regions (Figure 7B). Additionally, GLP1R+
cellular fractions (FACS) were significantly enriched for b and
d cells (Figure 7C). Finally, we observed a significant increase
in INS release from islets treated with 10 nM exenatide in high
glucose conditions, regardless of whether the islets originated
from healthy or T2D donors (Figure 7D). We conclude that the
islets are functional in terms of GLP1/GLP1R signaling and that
GLP1R protein expression was in agreement with the single-
cell RNA-seq data.
DISCUSSION
With the development of single-cell RNA-seq, high-throughput
profiling of transcriptomes across cell types, states, and sub-
populations has become feasible (Sandberg, 2014). Here, we
generated a unique resource of 2,209 full-length, single-cell tran-
scriptomes from cultured pancreatic islets of ten donors. Our
data are available through a user-friendly and searchable web
portal (http://sandberg.cmb.ki.se/pancreas). Unbiased analyses
of the data allowed the identification of cell types, demonstrating
that cell-type-specific gene expression programs were the
strongest determinant of the cellular transcriptomes. Impor-
tantly, due to the large number of profiled cells, we could simul-
taneously define the transcriptional signatures of both abundant
and rare cell types in the pancreas, including d, g, ε, stellate,
immune, and endothelial cells.
Despite the few numbers of scattered d and ε cells within the
islets of Langerhans, their transcriptomes hinted that they may
have important, previously unrecognized roles in islet homeosta-
sis.Withmultiple receptors, d cells could sense and react to a va-
riety of hormonal signals. First, they express the GHRL receptor,
which enables them to receive input locally from GHRL-produc-
ing ε cells and/or systemically from GHRL release from the intes-
tine during digestion.
In our transcriptional profile of d cells, we also uncovered that
they uniquely express the leptin receptor. Because leptin is
released predominantly from adipocytes (Fasshauer and Blu¨her,
2015), the initial pancreatic response to leptin levels could be
mediated through d cells. In this respect, it is also tempting to
speculate whether the scattered positions of d cells within hu-
man islets of Langerhans enable them to integrate both para-
crine and endocrine factors before using SST and other factors
(van der Meulen et al., 2015) to signal to their immediate
environment.
After assigning cells to cell types, it was apparent that cells
within cell types grouped according to donor (Figure S6). Onlyeristics
ale donors). Genes (rows) with a positive or negative correlation of at least 0.7 in
ered in descending order of BMI. Blue and red colors correspond to minimum
g Spearman’s correlation coefficients computed for the genes in each cell type
eatmap.
lation with BMI. The fitted curve in each scatter shows the linear regression
d on overall expression in donors (x axis) or for the specific indicated cell type
0.6 within a particular cell type that is also at least 10% higher in respect to the
A B
C
(legend on next page)
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Figure 7. Functional Analysis of GLP1R
(A) Boxplot showing expression of GLP1R in a, b, g, d, ε, acinar, and ductal cells, with color shadings representing different donors. Median and mean are
shown as a line and circle, respectively. Edges of each box indicate the 25th and 75th percentiles. Bars extend to extreme data points and outliers are plotted as
gray dots.
(B) Immunohistochemistry of pancreatic tissue for INS (brown) and GCG (red) (top left and zoom-in on top right), or GLP1R (brown) (lower left and zoom-in on
lower right).
(C) (Left) FACS analysis of islet cells stainedwith fluorescently conjugatedGLP1R antagonist. Gate shows fraction of the total islet cells positive for GLP1R. (Right)
Pie charts with the percentage of a, b, d, and other cells in FACS analyses of total islet cells (upper) or the GLP1R+ cellular fraction (lower), labeled with INS, GCG,
and SST antibodies.
(D) Dot plots showing GSIS of human islets from one healthy (left) and one T2D (right) donor treated with 16.7 mM glucose ± 10 nM Exenatide (Ex4).after correcting for donor differences were we able to identify
subpopulations and cellular states. The large number of profiled
cells allowed us to investigate the heterogeneity within each cell
type. Interestingly, we unraveled distinct sub-clusters of endo-
crine and exocrine cells, including proliferating a cells and sub-
sets of b cells with combinatorial expression of transcriptional
regulators. Moreover, we identified a group of acinar cells ex-
pressing MHC class II genes (CD74, HLA-DMA, HLA-DRA,
HLA-DRB1, and HLA-DRB5). MHC class II molecules are pre-
dominantly expressed by professional antigen-presenting cells.
In addition, peripheral cells in close contact with environmentalFigure 6. Altered Gene Expression in Cells from T2D Individuals
(A) Bar graphs showing the number of DE genes between cells from healthy and
(B)Heatmapswith theDEgenesbetweenhealthyandT2Da (left) andbcells (right). La
in the heatmap correspond to standardized log2 expression values, where each cell
(C) Heatmap of the enriched gene sets (using GSEA) within the a, b, g, d, acina
according to the adjusted p values (log10), with red and blue colors correspond
Sets with no significant enrichment are indicated with white color.
604 Cell Metabolism 24, 593–607, October 11, 2016cues for immunological reactions (e.g., intestinal epithelial cells,
airway epithelial cells, and keratinocytes) have been shown to
express MHC class II molecules (Kambayashi and Laufer,
2014). It is possible that the antigen-presenting acinar cells are
localized to pancreatic areas in closer contact with environ-
mental cues.
For metabolic diseases, it is expected that single-cell tran-
scriptome analyses can be paradigm changing. The single-cell
resolution allows for the parallel identification of disease-associ-
ated transcriptional alterations in each cell type independently
(Sandberg, 2014). Moreover, although islets or tissues in healthT2D donors per cell type.
bels indicating thediseasestatusandsexof thecells are shownonthe top.Colors
in the heatmap contains the distribution of values across the cells of each group.
r, and ductal cell types for healthy and T2D groups. The heatmap is colored
ing to enrichments among genes up- and downregulated in T2D, respectively.
and disease vary in cellular composition, single-cell transcrip-
tomics circumvents these challenges by first assigning cells to
cell types, which then allows comparisons in a cell-type resolved
manner. Our analyses revealed potential compensatory actions
for the lower b cell mass in T2D, including the downregulation
of FXYD2 and upregulation of GPD2. It is intriguing that mice
lacking FXYD2 had a pronounced pancreas phenotype with
increased proliferation of b cells (Arystarkhova et al., 2013).
The downregulation of FXYD2 could indicate an effort to stimu-
late b cell proliferation also in humans, but whether the function
of FXYD2 is shared in mice and men needs to be established.
Moreover, elevated levels of GPD2 in T2D b cells could increase
INS secretion via increase of NADH shuttles into mitochondria.
Finally, aberrations in mitochondrial respiratory functions were
also prominent in the functional gene enrichment results for
several cell types in the pancreas from the T2D donors.
In this study, we generated a resource of single-cell transcrip-
tomes from healthy and T2D donors that should be of great value
to the research community. Our computational analyses demon-
strated the power of cell-type resolved analyses and revealed
cell-type-specific gene expression programs, subpopulations,
and transcriptional alterations in T2D. Similar single-cell ana-
lyses of other metabolic tissues and pathologies will significantly
advance our understanding of heterogeneity within metabolic
tissues in health and disease.
EXPERIMENTAL PROCEDURES
Single-Cell RNA-Seq of Pancreatic Islets
Human tissue and primary islets were purchased fromProdo Laboratories Inc.,
providing islets isolated from donor pancreases obtained from deceased indi-
viduals with research consent fromOrgan Procurement Organizations (OPOs).
The use and storage of human islets and tissue samples were performed in
compliance with the Declaration of Helsinki, ICH/Good Clinical Practice and
was approved by the independent Regional Ethics Committee. Human islet
samples (85%–95% pure) were cultured for 4 days in complete Prodo Islet
Media Standard PIM(S) to recover after arrival. Islets were dissociated and
distributed by FACS into 384-well plates. Single-cell RNA-seq libraries were
produced with the Smart-seq2 protocol as previously described (Picelli
et al., 2014). Sequencing was carried out on an Illumina HiSeq 2000 generating
43 bp single-end reads.
RNA-Seq of Whole Islets
RNAwas isolated fromwhole islets from seven donors (healthy donors H3, H4,
and H6 and all T2D donors) using QIAGEN RNeasy Microkit with on-column
DNase digestion (QIAGEN) and processed with Illumina TruSeq Stranded
mRNA Library Prep Kit. Indexed libraries were pooled and sequenced
(paired-end 75 bp) on an Illumina NextSeq 500.
Single-Molecule mRNA Fluorescence In Situ Hybridization
mRNAs were visualized by single-molecule fluorescence in situ hybridization
(smFISH) using the RNAscope Fluorescent Multiplex Kit (Advanced Cell
Diagnostics, Inc.) on formalin-fixed, paraffin-embedded (FFPE) sections of
pancreas from four healthy donors. The following RNAscope probes were
used: Hs-GCG (ACD556741), hs-SST (ACD310591), hs-FAP (ACD411971),
and hs-LEPR (ACD406371). Images were acquired on a Nikon A1R confocal
microscope. See Table S3 for detailed information about how each cell was
counted together with the statistics per slide and donor.
Processing of RNA-Seq Data
Sequence reads were aligned toward the human genome (hg19 assembly) us-
ing STAR (v2.3.0e), and uniquely aligned reads within RefSeq gene annota-
tions were used to quantify gene expression as RPKMs using rpkmforgenes
(Ramsko¨ld et al., 2009).Cell-Type Classification
Cell-type classification was defined in a two-dimensional t-SNE space that
was constructed using a set of genes with highest biological variation. The
assignment of the formed clusters to cell types was performed based on the
expression levels of hormones or other known marker genes. The cell-type
classification of all cells analyzed is included in Table S1.
Differential Expression Analysis
Differential expression analysis between cell types (a, b, g, d, acinar, and
ductal cells) was performed using one-way ANOVA with log2-transformed
expression data from the five healthy male donors.
Analysis of Heterogeneity in the Cell Types
To investigate heterogeneity within cell types, single-cell expression data of
each cell type independently was ranked based on biological variability, and
using this as input, the cells were projected onto two dimensions with the
t-SNE. In all cases, the obtained embedding was dominated by donor differ-
ences (Figure S6). We applied a parametric empirical Bayesian framework to
remove donor differences and repeated the t-SNE dimensionality reduction
using the adjusted expression values.
Analyses of Gene Expression against BMI
Spearman’s r coefficients were calculated separately for each gene and cell
type based on the log2-transformed expression values. The results were
adjusted using Benjamini-Hochberg to control the false discovery rate
(a = 0.01). The five healthymale donors were used, since there is a positive cor-
relation between BMI and sex in our donors (r = 0.49). The lists containing
genes with an absolute correlation coefficient with BMI greater than 0.5 are
included in Table S5. We also generated gene correlations using all cells
(not separated per cell type) from the same five male donors to simulate the
correlations one would obtain in ‘‘whole-islet’’ analyses.
Differential Expression Analysis between Cells from Healthy and
T2D Donors
We identified statistically significant gene expression differences between
healthy and T2D individuals for the major cell types: a, b, g, d, acinar, and
ductal cells. Non-parametric one-way ANOVA (Kruskal-Wallis test) was used
after dividing samples into four groups based on disease status (healthy or
T2D) and sex. Bonferroni adjustment was used for the multiple comparison
correction and the Benjamini-Hochberg method to control the false discovery
rate at significance level a = 0.01. The genes that showed significant differ-
ences in respect to sex were excluded from the results in both tests in order
to identify the differentially expressed (DE) genes related to T2D.
GSEA in Cell Types
GSEA was used to examine whether the genes identified as DE between the
healthy and T2D cells for each cell type are members of categories with spe-
cific functions. We used the pre-ranked version, providing the difference in
median expression values between the healthy and T2D cells as the gene
ranking metric. The significant categories (FDR % 1%) that are enriched in
each cell type for the two conditions are reported in Table S7.
ACCESSION NUMBERS
Raw data (Fastq files) for single-cell and whole-islet RNA-seq have been
submitted to ArrayExpress (EBI) with accession numbers ArrayExpress:
E-MTAB-5061 and E-MTAB-5060, respectively.
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